About Molbio Diagnostics Limited IPO

Incorporated in October 2000, Molbio Diagnostics Limited is a healthcare technology company focused on developing and manufacturing point-of-care molecular diagnostic solutions. The company is best known for its proprietary Truenat platform, a portable, battery-operated PCR-based testing system that delivers accurate diagnostic results in less than an hour, making it well suite

Molbio Diagnostics IPO Subscription Breakdown

Investory CategorySubscription PercentageAmount Raised (₹ Crores)
Qualified Institutional Buyers (QIBs)50%58,23,123 crores
Non-Institutional Investors (NIIs)15%17,46,936.9 crores
Retail Individual Investors (RIIs)35%40,76,186.1 crores

Molbio Diagnostics IPO Strengths & Weaknesses

  • Proprietary Truenat platform with WHO-endorsed molecular diagnostic technology for tuberculosis.

  • Strong research and development capabilities supported by an extensive patent portfolio.

  • Scalable business model generating recurring revenue through diagnostic test kits.

  • Global presence across more than 90 countries with a strong institutional and government customer base.

  • Diversified healthcare portfolio strengthened through strategic acquisitions and an experienced management team.

Molbio Diagnostics IPO Important Dates & Issue Details

Allotment DateListing DateRefund Date
13 Aug '2617 Aug '2614 Aug '26
Issue Composition:
Face Value1 per share
Total Issue Size1,16,46,246 shares (aggregating up to To be announced)
Fresh Issue24,80,246 shares (aggregating up to ₹24,80,246 crores)
Offer for Sale91,66,000 shares of ₹1 (aggregating up to ₹91,66,000 crores)
Issue TypeBook Building IPO
Post-Issue Shareholding Pattern:
Pre-Issue Shareholding100 shares
Post-Issue Shareholding100 shares

Molbio Diagnostics IPO Lot Size and Investment Details

Minimum Lot Size18 shares
Maximum Lot Size (Retail)--

The lot size of Molbio Diagnostics ipo has been designed to ensure broad participation while maintaining optimal price discovery.

How to Apply for Molbio Diagnostics IPO

  1. Log in to your Choice account
  2. Select IPO
  3. Enter the number of lots and your price
  4. Verify UPI ID
  5. Complete the transaction on your UPI app

Molbio Diagnostics IPO Contact & Registrar Details

Contact Details

Address

Address

Plot No. L-46 Phase II-D, Verna Industrial Area Verna, Salcete South Goa

Phone Number

Phone Number

+91 8326724888

Registrar Details

Address

Registrar Name

Kfin Technologies Ltd.

Phone Number

Phone Number

+91 04079615565

Optivalue Tek Consulting Ltd IPO Lead Manager(s)

Book Running Lead Manager(s)
Kotak Mahindra Capital Co.Ltd. | IIFL Capital Services Ltd. | Jefferies India Pvt.Ltd. | Motilal Oswal Investment Advisors Ltd.

Molbio Diagnostics IPO FAQs

The minimum lot size is 18 shares with a price band of ₹ to ₹ per share, requiring a minimum investment of ₹.

Check allotment status on the registrar's website using PAN number or application number after the Molbio Diagnostics IPO allotment date.

The listing date of Molbio Diagnostics IPO is scheduled for 17 Aug '26 on NSE/BSE.

Investment decisions should be based on your risk appetite, financial goals, and a thorough analysis of the company's fundamentals and growth prospects.

Consider factors like company fundamentals, valuation, market conditions, and your investment portfolio before making any investment decision.

You can Molbio Diagnostics IPO apply online through your broker's trading platform, mobile app, or through the ASBA facility via internet banking.

The Molbio Diagnostics IPO allotment date and listing date are 13 Aug '26and 17 Aug '26, respectively.

Yes, you can apply through your bank's internet banking portal. The funds will remain in your account until allotment, and no need for separate IPO funding.